rs41282936

Variant summary

Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_153676.4(USH1C):​c.819+10G>C variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0133 in 1,614,136 control chromosomes in the GnomAD database, including 181 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.011 ( 17 hom., cov: 32)
Exomes 𝑓: 0.014 ( 164 hom. )

Consequence

USH1C
NM_153676.4 intron

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:9

Conservation

PhyloP100: -0.326
Variant links:
Genes affected
USH1C (HGNC:12597): (USH1 protein network component harmonin) This gene encodes a scaffold protein that functions in the assembly of Usher protein complexes. The protein contains PDZ domains, a coiled-coil region with a bipartite nuclear localization signal and a PEST degradation sequence. Defects in this gene are the cause of Usher syndrome type 1C and non-syndromic sensorineural deafness autosomal recessive type 18. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Mar 2009]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Benign. Variant got -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 11-17523409-C-G is Benign according to our data. Variant chr11-17523409-C-G is described in ClinVar as [Likely_benign]. Clinvar id is 48025.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr11-17523409-C-G is described in Lovd as [Likely_benign]. Variant chr11-17523409-C-G is described in Lovd as [Benign].
BS1
Variant frequency is greater than expected in population nfe. gnomad4 allele frequency = 0.0106 (1608/152300) while in subpopulation NFE AF= 0.0175 (1189/68024). AF 95% confidence interval is 0.0167. There are 17 homozygotes in gnomad4. There are 719 alleles in male gnomad4 subpopulation. Median coverage is 32. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 17 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE Protein UniProt
USH1CNM_005709.4 linkuse as main transcriptc.819+10G>C intron_variant ENST00000318024.9 NP_005700.2
USH1CNM_153676.4 linkuse as main transcriptc.819+10G>C intron_variant ENST00000005226.12 NP_710142.1

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Protein Appris UniProt
USH1CENST00000005226.12 linkuse as main transcriptc.819+10G>C intron_variant 5 NM_153676.4 ENSP00000005226 Q9Y6N9-5
USH1CENST00000318024.9 linkuse as main transcriptc.819+10G>C intron_variant 1 NM_005709.4 ENSP00000317018 P1Q9Y6N9-1

Frequencies

GnomAD3 genomes
AF:
0.0106
AC:
1608
AN:
152182
Hom.:
17
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00294
Gnomad AMI
AF:
0.0143
Gnomad AMR
AF:
0.00628
Gnomad ASJ
AF:
0.0190
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000414
Gnomad FIN
AF:
0.00914
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0175
Gnomad OTH
AF:
0.0105
GnomAD3 exomes
AF:
0.0107
AC:
2689
AN:
251442
Hom.:
28
AF XY:
0.0104
AC XY:
1415
AN XY:
135890
show subpopulations
Gnomad AFR exome
AF:
0.00265
Gnomad AMR exome
AF:
0.00454
Gnomad ASJ exome
AF:
0.0212
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000490
Gnomad FIN exome
AF:
0.0111
Gnomad NFE exome
AF:
0.0172
Gnomad OTH exome
AF:
0.0109
GnomAD4 exome
AF:
0.0136
AC:
19859
AN:
1461836
Hom.:
164
Cov.:
33
AF XY:
0.0133
AC XY:
9705
AN XY:
727214
show subpopulations
Gnomad4 AFR exome
AF:
0.00218
Gnomad4 AMR exome
AF:
0.00523
Gnomad4 ASJ exome
AF:
0.0207
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.000730
Gnomad4 FIN exome
AF:
0.0118
Gnomad4 NFE exome
AF:
0.0158
Gnomad4 OTH exome
AF:
0.0125
GnomAD4 genome
AF:
0.0106
AC:
1608
AN:
152300
Hom.:
17
Cov.:
32
AF XY:
0.00965
AC XY:
719
AN XY:
74480
show subpopulations
Gnomad4 AFR
AF:
0.00294
Gnomad4 AMR
AF:
0.00628
Gnomad4 ASJ
AF:
0.0190
Gnomad4 EAS
AF:
0.00
Gnomad4 SAS
AF:
0.000414
Gnomad4 FIN
AF:
0.00914
Gnomad4 NFE
AF:
0.0175
Gnomad4 OTH
AF:
0.0104
Alfa
AF:
0.0175
Hom.:
4
Bravo
AF:
0.00962
Asia WGS
AF:
0.00115
AC:
4
AN:
3478

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:9
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
Likely benign, no assertion criteria providedclinical testingClinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center-- -
Benign, criteria provided, single submitterclinical testingLabcorp Genetics (formerly Invitae), LabcorpJan 31, 2024- -
Benign, criteria provided, single submitterclinical testingARUP Laboratories, Molecular Genetics and Genomics, ARUP LaboratoriesOct 03, 2023- -
Likely benign, criteria provided, single submitternot providedBreakthrough Genomics, Breakthrough Genomics-- -
not specified Benign:3
Benign, no assertion criteria providedclinical testingJoint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+-- -
Benign, criteria provided, single submitterclinical testingLaboratory for Molecular Medicine, Mass General Brigham Personalized MedicineMay 29, 2012819+G>C in intron 10 of USH1C: This variant is not expected to have clinical sig nificance because it has been identified in 1.7% (122/7020) of European American chromosomes and 0.1% (4/3738) of African American chromosomes from a broad popu lation by the NHLBI Exome Sequencing Project (http://evs.gs.washington.edu/EVS/; dbSNP rs41282936). -
Benign, criteria provided, single submitterclinical testingGeneDxMay 12, 2013This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -
Usher syndrome type 1C Benign:2
Likely benign, criteria provided, single submitterclinical testingIllumina Laboratory Services, IlluminaJan 12, 2018This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -
Benign, no assertion criteria providedclinical testingNatera, Inc.Sep 16, 2020- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.2
DANN
Benign
0.73

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs41282936; hg19: chr11-17544956; COSMIC: COSV50014818; COSMIC: COSV50014818; API